Fifth Third Bancorp increased its stake in shares of Chemed Corporation (NYSE:CHE – Free Report) by 235.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,697 shares of the company’s stock after acquiring an additional 6,807 shares during the quarter. Fifth Third Bancorp’s holdings in Chemed were worth $3,663,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of CHE. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Chemed by 2,444,879.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after purchasing an additional 5,549,876 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Chemed by 4.4% in the 4th quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock worth $223,301,000 after acquiring an additional 21,932 shares during the period. AQR Capital Management LLC lifted its position in shares of Chemed by 89.2% in the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock worth $139,302,000 after acquiring an additional 153,469 shares during the period. TD Asset Management Inc grew its holdings in shares of Chemed by 7.5% during the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after purchasing an additional 22,715 shares in the last quarter. Finally, Epoch Investment Partners Inc. increased its position in shares of Chemed by 4.9% during the fourth quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock valued at $137,945,000 after purchasing an additional 15,133 shares during the period. 95.85% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on CHE shares. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Bank of America raised their price objective on shares of Chemed from $450.00 to $510.00 and gave the stock a “neutral” rating in a report on Thursday, July 9th. Wall Street Zen cut shares of Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday. Finally, Royal Bank Of Canada lifted their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Chemed presently has an average rating of “Hold” and an average target price of $480.25.
Insider Transactions at Chemed
In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the transaction, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 3.33% of the company’s stock.
Chemed Trading Down 0.0%
Shares of CHE opened at $509.89 on Monday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The company has a market cap of $6.77 billion, a price-to-earnings ratio of 27.79, a PEG ratio of 1.88 and a beta of 0.52. The stock has a fifty day moving average price of $450.37 and a two-hundred day moving average price of $430.90. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $511.85.
Chemed (NYSE:CHE – Get Free Report) last announced its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. During the same period last year, the company posted $5.63 earnings per share. The firm’s quarterly revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Analysts predict that Chemed Corporation will post 22.67 EPS for the current fiscal year.
Chemed Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were given a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is presently 13.08%.
Chemed Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
See Also
- Five stocks we like better than Chemed
- Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
- Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet
- Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
